Petros Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Petros Pharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.53 | $-0.29 | -82.8 % |
Q2 | 2024-08-14 | $-0.37 | $-0.77 | 51.9 % |
Q1 | 2024-05-15 | $-1.69 | $-1.44 | -17.4 % |
Q4 | 2024-04-01 | $-2.17 | $-1.11 | -95.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $1.58M | $1.34M | 17.6 % |
Q2 | 2024-08-14 | $1.42M | $1.40M | 1.50 % |
Q1 | 2024-05-15 | $1.39M | $1.45M | -4.21 % |
Q4 | 2024-04-01 | $364.25K | $1.55M | -76.5 % |
Petros Pharma (PTPI) is scheduled to report earnings on March 31, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.53, which missed the estimate of $-0.29.
The Actual Revenue was $1.6M, which beat the estimate of $1.3M.
Browse earnings estimates, EPS, and revenue on all stocks.